Bioactive Compounds
-
BA2299 SSAA09E3Summary: SSAA09E3 is an entry inhibitor. -
N2083 Ligustroflavone -
BA2298 SARS-CoV-2-IN-14Summary: SARS-CoV-2-IN-14 is a potent inhibitor. -
BA2297 MERS-CoV-IN-1Summary: Compositions of active molecules that can be used as prophylaxis against diseases caused by MERS-CoV and SARS viruses. -
N2038 lithospermic acid -
BA2296 LY1Summary: LY1 is a potent and selective covalent inhibitor against and. -
BA2295 SARS-CoV-2-IN-39Summary: SARS-CoV-2-IN-39 (compound 21) is an inhibitor. -
N2012 Pulchinenoside B -
BA2294 SARS-CoV-2-IN-7Summary: SARS-CoV-2-IN-7 in SARS-CoV-2-infected VeroE6 cells in nanomoles. -
N1959 Trifolirhizin;(-)-Maackiain-3-O-glucoside

